Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease.

Publication ,  Journal Article
Stewart, RAH; Held, C; Krug-Gourley, S; Waterworth, D; Stebbins, A; Chiswell, K; Hagstrom, E; Armstrong, PW; Wallentin, L; White, H
Published in: J Am Heart Assoc
April 2, 2019

Background Vascular risk factors have been associated with differences in cognitive performance in epidemiological studies, but evidence in patients with coronary heart disease is more limited. Methods and Results The Montreal Cognitive Assessment score obtained 3.2±0.37 years after randomization to darapladib, a reversible inhibitor of lipoprotein phospholipase A2 or placebo was evaluated for 10 634 patients with coronary heart disease from 38 countries in the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) trial. The Montreal Cognitive Assessment scores for darapladib and placebo groups were similar (mean± SD , 25.3±3.84 versus 25.4±3.73, respectively; P=0.27) and the adjusted odds ratio ( OR ) for mild cognitive impairment (Montreal Cognitive Assessment score <26) was 1.00 (95% CI , 0.93-1.09). Mild cognitive impairment was more likely with increasing age ( OR , 1.33 [1.27-1.41], +5 years after 65). For other baseline clinical characteristics, the strongest independent predictors of cognitive impairment were education (≤8 years versus college/university, OR , 2.95 [2.60-3.35]; >8 years/trade school versus college/university, OR , 1.38 [1.25-1.52] and geographic grouping). Cardiovascular risk factors independently associated with cognitive impairment were history of stroke ( OR , 1.43 [1.20-1.71]); <2.5 hours of moderate or vigorous intensity exercise/week ( OR , 1.19 [1.04-1.37]); high-density lipoprotein cholesterol <1.16 mmol/L ( OR , 1.19 [1.04-1.37]); diabetes mellitus requiring treatment ( OR , yes versus no: 1.15 [1.05-1.26]); and history of hypertension ( OR , 1.12 [1.02-1.23]). Conclusions In patients with stable coronary heart disease, cognitive performance was associated with modifiable cardiovascular risk factors, educational level, and global region, but was not influenced by darapladib. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 00799903.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

April 2, 2019

Volume

8

Issue

7

Start / End Page

e010641

Location

England

Related Subject Headings

  • Stroke
  • Risk Factors
  • Phospholipase A2 Inhibitors
  • Oximes
  • Middle Aged
  • Male
  • Humans
  • Female
  • Exercise
  • Coronary Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stewart, R. A. H., Held, C., Krug-Gourley, S., Waterworth, D., Stebbins, A., Chiswell, K., … White, H. (2019). Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease. J Am Heart Assoc, 8(7), e010641. https://doi.org/10.1161/JAHA.118.010641
Stewart, Ralph A. H., Claes Held, Sue Krug-Gourley, Dawn Waterworth, Amanda Stebbins, Karen Chiswell, Emil Hagstrom, Paul W. Armstrong, Lars Wallentin, and Harvey White. “Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease.J Am Heart Assoc 8, no. 7 (April 2, 2019): e010641. https://doi.org/10.1161/JAHA.118.010641.
Stewart RAH, Held C, Krug-Gourley S, Waterworth D, Stebbins A, Chiswell K, et al. Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease. J Am Heart Assoc. 2019 Apr 2;8(7):e010641.
Stewart, Ralph A. H., et al. “Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease.J Am Heart Assoc, vol. 8, no. 7, Apr. 2019, p. e010641. Pubmed, doi:10.1161/JAHA.118.010641.
Stewart RAH, Held C, Krug-Gourley S, Waterworth D, Stebbins A, Chiswell K, Hagstrom E, Armstrong PW, Wallentin L, White H. Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease. J Am Heart Assoc. 2019 Apr 2;8(7):e010641.
Journal cover image

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

April 2, 2019

Volume

8

Issue

7

Start / End Page

e010641

Location

England

Related Subject Headings

  • Stroke
  • Risk Factors
  • Phospholipase A2 Inhibitors
  • Oximes
  • Middle Aged
  • Male
  • Humans
  • Female
  • Exercise
  • Coronary Disease